Immunotherapy Duo Trumps Single Agent in Metastatic Bladder Cancer – Curetoday.com
Curetoday.com |
Immunotherapy Duo Trumps Single Agent in Metastatic Bladder Cancer
Curetoday.com Immunotherapy Duo Trumps Single Agent in Metastatic Bladder Cancer. Patients with metastatic bladder cancer who did not see a benefit on single-agent Opdivo did better when the drug was combined with Yervoy, a recent study showed. PUBLISHED: … |
